Macter International Limited (PSX:MACTER)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
314.20
-3.23 (-1.02%)
At close: Feb 27, 2026
4.99%
Market Cap 14.39B
Revenue (ttm) 11.58B
Net Income (ttm) 815.46M
Shares Out 45.81M
EPS (ttm) 17.80
PE Ratio 17.65
Forward PE n/a
Dividend 3.80 (1.21%)
Ex-Dividend Date Oct 16, 2025
Volume 8,081
Average Volume 31,250
Open 315.00
Previous Close 317.43
Day's Range 312.02 - 318.00
52-Week Range 270.00 - 621.82
Beta 0.12
RSI 36.80
Earnings Date Feb 14, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1992
Employees 1,282
Stock Exchange Pakistan Stock Exchange
Ticker Symbol MACTER
Full Company Profile

Financial Performance

In fiscal year 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.

Financial Statements

News

There is no news available yet.